1. Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999). Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156: 1758–1764.
2. Boxenbaum HG, Riegelman S, Elashoff RM (1974). Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm 2: 123–148.
3. CAN (2001). Drogutvecklingen i Sverige, rapport 99. Rapport nr10 (1999). Folkhälsoinstitutet: Centralförbundet för Alkol och Narkotikaupplysning, Stockholm [The development of drug use in Sweden, report 2001].
4. Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R et al (2000). A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 35: 587–593.
5. Cushman P Jr, Kreek MJ (1974). Methadone-maintained patients. Effect of methadone on plasma testosterone, FSH, LH, and prolactin. NY State J Med 74: 1970–1973.